Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The investigators´aim is to assess whether the progestagen dienogest reduces leiomyoma volume
and its associated symptoms to the same extent as gonadotropin releasing hormone (GnRH)
analogs or the progestagen desogestrel or whether it is inferior to other drugs already in
use.